Minerva Monroy-Barreto

Minerva Monroy-Barreto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Minerva Monroy-Barreto has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial

    by Lilia Gutierrez, Graciela Tapia, Luis Ocampo, Minerva Monroy-Barreto, Hector Sumano

    An outpatient clinical trial on unresponsive deep-bacterial canine pyoderma (UDCP), without a control group, is presented. The chosen treatment was implemented with a new crystal-solvate of enrofloxacin (enrofloxacin HCl-2H2O or enro-C), in a dual scheme, i.e., 10 mg/kg/day PO, plus its topical administration, prepared as 0.5% in an alginate gel, thrice per day. Fifty-five cases that were unsuccessfully treated previously with another antibacterial drug, were selected and then classified as severe or very severe, according to a clinical score tailored for this trial. Aerobic bacteriological cultures of skin lesions and antibacterial sensitivity tests, were performed. Hematological status, liver, and kidney functions were determined before and after treatment. A complete success was obtained in 32 severe and 23 very severe, cases. The main bacterial isolates were: Staphylococcus intermedius (19/99), Staphylococcus pseudintermedius (16/99), Staphylococcus epidermidis (15/99), Staphylococcus pyogenes (14/99), Staphylococcus saprophyticus, Streptococcus sp., and others including Pseudomonas aeruginosa (6/99). The average duration of treatment was 8.03 days ± 2.1 SD and 12.0 ± 2.4 days, for dogs with severe or very severe UDCP, respectively. The adverse effects caused by enro-C were inconsequential and the hematological tests showed no deviations from normality. The use of enro-C administered dually to treat UDCP, is considered safe and highly effective.


  • Characterization and study of microwave activation effects on the polystyrene tacticity

    by Josue L. Figueroa-Campos, Minerva Monroy-Barreto, Joaquín Palacios-Alquisira

    13C Nuclear magnetic resonance proved to be an advantageous tool to determine the stereoregularity of polystyrene polymers. The latter was achieved through the analysis of the signal of the quaternary carbon and that of the carbon-p in the aromatic ring too. Styrene was polymerized through microwaves and conventional heating activation using two different polymerization techniques: emulsion and bulk. Microwave activation was performed in a mono-modal type device under the following experimental conditions: various initiator concentrations, an average irradiation power of 50 W, temperature of 70°C, and using a batch reactor for emulsion and bulk experiments. The results obtained in these experiments were compared with those obtained by conventional heating activation polymerization under the same initiator concentration and temperature conditions. Microwave-activated reactions resulted in shorter reaction times and higher yields. The tacticity of the polymer samples was not significantly altered, which lead to the conclusion that, in this case, the stereoregularity of polystyrene was not influenced by microwave irradiation.